Inclusive trial access Inato focuses on expanding trial access beyond traditional top sites to community-based research sites, presenting a growth opportunity to partner with sponsors seeking broader patient populations and faster enrollment timelines.

Sponsor-site match The platform enables exclusive site profiles and verification processes, enabling sponsors to reliably identify and engage underutilized sites, which can translate into upsell opportunities for premium placement, data services, and enrollment optimization.

Market expansion With a mission to diversify participation and accelerate research, there is potential to target mid-market biotechs and global pharmas looking to de-risk trials by sourcing diverse sites, improving timelines and enrollment targets.

Tech-enabled efficiency Leveraging a tech stack that includes AI elements (OpenAI) and cloud delivery suggests opportunities to bundle AI-driven site scoring, trial matching, and performance analytics as value-added offerings.

Financial potential Reported revenue in mid-range and a mid-sized employee base indicate room to propose scalable SaaS licenses, premium support, and data integration services to larger patients-centric health tech firms seeking similar adoption.